The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The ever‐increasing importance of cancer as a leading cause of premature death worldwide
Open accessAbstract
The relative importance of cardiovascular disease (CVD) and cancer as leading causes of premature death are examined in this communication. CVD and cancer are now the leading causes in 127 countries, with CVD leading in 70 countries (including Brazil and India) and cancer leading in 57 countries (including China). Such observations can be seen as part of a late phase of an epidemiologic transition, taking place in the second half of the 20th century and the first half of the present one, in which the dominance of infectious diseases is progressively superseded by noncommunicable diseases. According to present ranks and recent trends, cancer may surpass CVD as the leading cause of premature death in most countries over the course of this century. Clearly, governments must factor in these transitions in developing cancer policies for the local disease profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4
Bennett, J. E., Kontis, V., Mathers, C. D., Guillot, M., Rehm, J., Chalkidou, K., Kengne, A. P., Carrillo-Larco, R. M., Bawah, A. A., Dain, K., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31761-x · Cited by 447
Bray, F., & Soerjomataram, I. (2015) · Disease Control Priorities, Third Edition (Volume 3): Cancer · doi:10.1596/978-1-4648-0349-9_ch2 · Cited by 209
Self-citationGelband, H., Sankaranarayanan, R., Gauvreau, C. L., Horton, S., Anderson, B. O., Bray, F., Cleary, J., Dare, A. J., Denny, L., Gospodarowicz, M. K., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00755-2 · Cited by 205
Self-citationNational cancer control plans: a global analysis
Romero, Y., Trapani, D., Johnson, S., Tittenbrun, Z., Given, L., Hohman, K., Stevens, L., Torode, J. S., Boniol, M., & Ilbawi, A. M. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30681-8 · Cited by 199
Cancer mortality in Europe, 1990–1994, and an overview of trends from 1955 to 1994
Levi, F., Lucchini, F., Negri, E., Boyle, P., & Vecchia, C. L. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00154-9 · Cited by 150
Core elements of national cancer control plans: a tool to support plan development and review
Oar, A. J., de Moraes, F. Y., Romero, Y., Ilbawi, A., & Yap, M. L. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30404-8 · Cited by 64
World Population Prospects 2019 - Volume II: Demographic Profiles
Nations, U. (2020) · doi:10.18356/7707d011-en · Cited by 46
Cited by
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Self-citationBray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
Self-citationCancer statistics in China and United States, 2022: profiles, trends, and determinants
Xia, C., Dong, X., Li, H., Cao, M., Sun, D., He, S., Yang, F., Yan, X., Zhang, S., Li, N., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002108 · Cited by 3,402
Janesick, A., Shelansky, R., Gottscho, A. D., Wagner, F., Williams, S. R., Rouault, M., Beliakoff, G., Morrison, C. A., Oliveira, M. F., Sicherman, J. T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43458-x · Cited by 909
Anjum, S., Hashim, M., Malik, S. A., Khan, M., Lorenzo, J. M., Abbasi, B. H., & Hano, C. (2021) · Cancers · doi:10.3390/cancers13184570 · Cited by 575
Metadata
- Authors
- Bray, F., Laversanne, M., Weiderpass, E., & Soerjomataram, I.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2021-06-04
- Volume
- 127
- Issue
- 16
- Pages
- 3029-3030
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W3165720345
- Cited by
- 2,591
- References
- 7
- FWCI
- 130.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.